Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nobuyuki Ebihara

Showing results (1-10 of 170) with videos related to

Pageof 17
Sort By:
Arerugi = [Allergy]|December 2, 2010
[New strategy in the treatment of vernal keratoconjunctivitis by calcineurin inhibitor eye drops]Nobuyuki Ebihara
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 16, 2005
[Allergic conjunctival disorders]Nobuyuki Ebihara
Arerugi = [Allergy]|September 30, 2021
[TREATMENT OF SEVERE ALLERGIC CONJUNCTIVITIS IN JAPAN, FOCUS ON IMMUNOSUPPRESSIVE EYE DROPS]Nobuyuki Ebihara
Arerugi = [Allergy]|September 15, 2017
ALLERGIC CONJUNCTIVAL DISORDERS AND THE BARRIER FUNCTION OF CONJUNCTIVA, FOCUSING ON TEARS AND CALTNobuyuki Ebihara
Arerugi = [Allergy]|September 13, 2016
STRATEGIES OF THE TREATMENT TO REFRACTORY ALLERGIC CONJUNCTIVAL DISORDERSNobuyuki Ebihara
Arerugi = [Allergy]|May 29, 2014
[Pregnancy and eye]Nobuyuki Ebihara
Arerugi = [Allergy]|November 14, 2017
[Erratum : ALLERGIC CONJUNCTIVAL DISORDERS AND THE BARRIER FUNCTION OF CONJUNCTIVA, FOCUSING ON TEARS AND CALT [Japanese Journal of Allergology Vol.66 (2017) No.8 p.1001-1006]]Nobuyuki Ebihara
Arerugi = [Allergy]|July 14, 2017
Erratum : STRATEGIES OF THE TREATMENT TO REFRACTORY ALLERGIC CONJUNCTIVAL DISORDERS [Japanese Journal of Allergology Vol.65 (2016) No.8 p.994-998]Nobuyuki Ebihara
Advances in Therapy|October 2, 2014
Efficacy of olopatadine versus epinastine for treating allergic conjunctivitis caused by Japanese cedar pollen: a double-blind randomized controlled trialAtsuki Fukushima, Nobuyuki Ebihara
Japanese Journal of Ophthalmology|November 21, 2025
Clinical characteristics and management of dupilumab-associated ocular surface disease in JapanJun Shoji, Nobuyuki Ebihara
Pageof 17

Showing results (1-10 of 170) with videos related to

Sort By:
Pageof 17
Arerugi = [Allergy]|December 2, 2010
[New strategy in the treatment of vernal keratoconjunctivitis by calcineurin inhibitor eye drops]Nobuyuki Ebihara
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 16, 2005
[Allergic conjunctival disorders]Nobuyuki Ebihara
Arerugi = [Allergy]|September 30, 2021
[TREATMENT OF SEVERE ALLERGIC CONJUNCTIVITIS IN JAPAN, FOCUS ON IMMUNOSUPPRESSIVE EYE DROPS]Nobuyuki Ebihara
Arerugi = [Allergy]|September 15, 2017
ALLERGIC CONJUNCTIVAL DISORDERS AND THE BARRIER FUNCTION OF CONJUNCTIVA, FOCUSING ON TEARS AND CALTNobuyuki Ebihara
Arerugi = [Allergy]|September 13, 2016
STRATEGIES OF THE TREATMENT TO REFRACTORY ALLERGIC CONJUNCTIVAL DISORDERSNobuyuki Ebihara
Arerugi = [Allergy]|May 29, 2014
[Pregnancy and eye]Nobuyuki Ebihara
Arerugi = [Allergy]|November 14, 2017
[Erratum : ALLERGIC CONJUNCTIVAL DISORDERS AND THE BARRIER FUNCTION OF CONJUNCTIVA, FOCUSING ON TEARS AND CALT [Japanese Journal of Allergology Vol.66 (2017) No.8 p.1001-1006]]Nobuyuki Ebihara
Arerugi = [Allergy]|July 14, 2017
Erratum : STRATEGIES OF THE TREATMENT TO REFRACTORY ALLERGIC CONJUNCTIVAL DISORDERS [Japanese Journal of Allergology Vol.65 (2016) No.8 p.994-998]Nobuyuki Ebihara
Advances in Therapy|October 2, 2014
Efficacy of olopatadine versus epinastine for treating allergic conjunctivitis caused by Japanese cedar pollen: a double-blind randomized controlled trialAtsuki Fukushima, Nobuyuki Ebihara
Japanese Journal of Ophthalmology|November 21, 2025
Clinical characteristics and management of dupilumab-associated ocular surface disease in JapanJun Shoji, Nobuyuki Ebihara
Pageof 17